Intended for healthcare professionals

Letters An emerging problem

Urinary tract disease associated with chronic ketamine use

BMJ 2008; 336 doi: https://doi.org/10.1136/bmj.39562.711713.80 (Published 01 May 2008) Cite this as: BMJ 2008;336:973

This article has a correction. Please see:

  1. Angela M Cottrell, clinical research fellow1,
  2. Rachel Athreeres, volunteer manager2,
  3. Pete Weinstock, senior practitioner2,
  4. Kate Warren, urology registrar3,
  5. David Gillatt, consultant urological surgeon4
  1. 1Bristol Urological Institute, Southmead Hospital, Bristol BS10 5NB
  2. 2Bristol Drug Project, Bristol BS2 8PE
  3. 3Weston General Hospital, Weston super Mare BS23 4TQ
  4. 4Bristol Urological Institute, Bristol
  1. angecottrell{at}hotmail.com

Regarding the case study by Dhillon et al,1 we have seen an alarming increase in people presenting to urological services in South West England with bladder symptoms associated with chronic ketamine use. Two case series in Hong Kong and Canada have been published, but ketamine associated bladder pathology has not been reported in the UK.2 3

Over the past two years, nine …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription